Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 675 of 3546 entries
View as:

Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years

Phase: N/A Priority: Normal
NCT ID: NCT00346073 Org: User:
Start: 07/13/06 End: 03/07/07 Due: 03/07/08

Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02281370 Org: User:
Start: 11/05/14 End: 12/24/14 Due: 12/24/15

A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose

Phase: N/A Priority: Normal
NCT ID: NCT00439881 Org: User:
Start: 10/31/06 End: - Due: -

QTc Study GSK573719+GW642444

Phase: N/A Priority: Normal
NCT ID: NCT01521377 Org: User:
Start: 12/19/11 End: 06/05/12 Due: 06/05/13

Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

Phase: N/A Priority: Normal
NCT ID: NCT01390805 Org: User:
Start: 11/30/06 End: 03/31/11 Due: 03/31/12

Intranasal SB-705498 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00907933 Org: User:
Start: 11/10/08 End: 02/11/09 Due: 02/11/10

Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05124210 Org: User:
Start: 12/16/21 End: 06/14/23 Due: 06/14/24

Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

Phase: N/A Priority: Normal
NCT ID: NCT00929526 Org: User:
Start: 06/30/09 End: 02/28/11 Due: 02/28/12

A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution

Phase: N/A Priority: Normal
NCT ID: NCT02751294 Org: User:
Start: 05/31/16 End: 08/31/16 Due: 08/31/17

A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation

Phase: N/A Priority: Normal
NCT ID: NCT00910962 Org: User:
Start: 10/08/09 End: 03/06/12 Due: 03/06/13

Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)

Phase: N/A Priority: Normal
NCT ID: NCT01428544 Org: User:
Start: 03/31/12 End: 06/30/15 Due: 06/30/16

Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00530309 Org: User:
Start: 08/01/07 End: 04/17/08 Due: 04/17/09

Bioequivalence Study of an Amoxicillin-Clavulanic

Phase: N/A Priority: Normal
NCT ID: NCT01772238 Org: User:
Start: 03/22/11 End: 03/30/11 Due: 03/30/12

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01762878 Org: User:
Start: 01/09/13 End: 10/21/13 Due: 10/21/14

Assessment of the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in the Serum of Infants and Toddlers, Following Administration of IPV (Inactivated Poliovirus Vaccine)-Containing Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT01651247 Org: User:
Start: 05/31/10 End: 05/31/10 Due: 05/31/11

Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT04502693 Org: User:
Start: 08/14/20 End: 09/13/22 Due: 09/13/23

Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg)

Phase: N/A Priority: Normal
NCT ID: NCT00358371 Org: User:
Start: 01/06/05 End: 02/08/05 Due: 02/08/06

Trends Over Time (1990-2010) of Diarrhoea-related Hospitalizations and Deaths in Children < 5 Years of Age in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT01175252 Org: User:
Start: 12/31/08 End: 06/30/12 Due: 06/30/13

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

Phase: N/A Priority: Normal
NCT ID: NCT06979323 Org: User:
Start: 06/10/25 End: 02/11/28 Due: 02/11/29

Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00486954 Org: User:
Start: 07/31/07 End: 10/31/12 Due: 10/31/13

Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug

Phase: N/A Priority: Normal
NCT ID: NCT00520663 Org: User:
Start: 06/08/07 End: 08/10/07 Due: 08/10/08

Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05260437 Org: User:
Start: 03/24/22 End: 03/07/23 Due: 03/07/24

Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00043914 Org: User:
Start: 01/14/02 End: 01/29/03 Due: 01/29/04

Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza

Phase: N/A Priority: Normal
NCT ID: NCT02469298 Org: User:
Start: 06/01/15 End: 04/25/16 Due: 04/25/17

Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT01915888 Org: User:
Start: 08/31/13 End: 02/28/14 Due: 02/28/15